prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, AP Surgical Pathology: Final. CLINICAL HISTORY: Left ca breast. GROSS EXAMINATION: A. "Sentinel node # 1 hot and blue", received fresh and placed in formalin. A. 1.8 x 1.4 x 0.8 cm lymph node candidate with attached adipose tissue is. sectioned and submitted in toto in A1. A cytokeratin stain is prospectively. requested. B. "Sentinel node # 2 hot and blue", received fresh and placed in formalin. A. 1.4 x 1.2 x 0.7 cm lymph node candidate with attached adipose tissue is. sectioned and submitted in B1. A cytokeratin stain is prospectively. requested. C. "Sentinel node # 3 hot not blue", received fresh and placed in formalin. A. 1.3 x 0.8 x 0.5 cm lymph node candidate with attached adipose tissue is. sectioned and submitted in C1. A cytokeratin stain is prospectively. requested. D. "Left breast partial mastectomy skin anterior, short superior, long. lateral", received fresh and placed in formalin. A partial mastectomy. specimen with the following measurements: medial-lateral 7.5 cm, anterior. posterior 6 cm, superior-inferior 2.5 cm. The overlying skin measures 4.2 x. 1.8 cm, and the specimen is inked as follows: superior-red, inferior-yellow,. anterior-blue, posterior-black. The specimen is serially sectioned from. medial to lateral, revealing a firm, ill-defined mass measuring roughly 1 x. 0.7 x 0.7 cm. The mass is 0.7 cm from the anterior margin, 1.2 cm from the. superior margin, 2.3 cm from inferior margin, 1.6 cm from the posterior. margin, 3 cm from the medial margin, and 4 cm from the lateral margin. The. remainder of the specimen is composed of yellow fibroadipose tissue with thin. delicate bands of breast tissue, no other lesions are identified. BLOCK SUMMARY: D1-2- medial margin, bisected. D3- superior portion of fourth slice from medial, thinned. D5-6- anterior middle portion of fourth slice, thinned. D7-8- posterior middle portion of fourth slice, thinned. D9-10- inferior portion of fourth slice, thinned. D11-12- superior portion of fifth slice, thinned. D13-14- anterior middle section of fifth slice, thinned. D15-16- posterior middle portion of fifth slice, thinned. D17-18- inferior portion of fifth slice, thinned. D19- superior portion of sixth slice, thinned. D20- anterior middle portion of sixth slice, thinned. D21- posterior middle portion of sixth slice, thinned. D22- inferior portion of sixth slice, thinned. D23- superior portion of seventh slice, thinned. D24- middle portion of seventh slice, thinned. D25- inferior portion of seventh slice, thinned. D26- lateral margin. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: LEFT PARTIAL MASTECTOMY AND SENTINEL LYMPH NODE DISSECTION. PATHOLOGIC STAGE (AJCC. Edition) : pT1b pNO (sn) (i-) pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. the current tissue specimen being evaluated, and does not incorporate. upon information on any specimens submitted separately to our Cytology section,. past findings. Pathology stage is only a component to be considered in determining it. pathology information, imaging studies, or clinical or operative. the clinical stage, and should not be confused with nor substituted for. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. "SENTINEL NODE #1" (EXCISION) : ONE LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA (0/1) . AN IMMUNOHISTOCHEMICAL STAIN FOR CYTOKERATIN IS NEGATIVE FOR TUMOR CELLS. B. "SENTINEL NODE #2" (EXCISION) : ONE LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA (0/1) . AN IMMUNOHISTOCHEMICAL STAIN FOR CYTOKERATIN IS NEGATIVE FOR TUMOR CELLS. C. "SENTINEL NODE #3" (EXCISION) : ONE LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA (0/1) . AN IMMUNOHISTOCHEMICAL STAIN FOR CYTOKERATIN IS NEGATIVE FOR TUMOR CELLS. D. "LEFT BREAST" (PARTIAL MASTECTOMY) : INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: LOBULAR. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 2 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 2. MITOTIC RATE SCORE: 2. GROSS TUMOR SIZE: 1 x 0.7 x 0.7 CM. SIZE OF INVASIVE COMPONENT: 1 CM. LYMPHATIC/VASCULAR INVASION: ABSENT. MULTIFOCAL TUMOR: ABSENT. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: DUCTAL, SOLID TYPE. NUCLEAR GRADE OF IN-SITU CARCINOMA: 2 OF 3. NECROSIS: ABSENT. DCIS EXTENDING OUTSIDE INVASIVE TUMOR MASS: PRESENT, AT EDGE OF TUMOR. STATUS OF NON-NEOPLASTIC BREAST TISSUE: BIOPSY SITE CHANGES, FIBROCYSTIC. CHANGE. SKIN STATUS: NEGATIVE FOR MALIGNANCY. SIZE OF BIOPSY: 7.5 x 6 x 2.5 CM. MICROCALCIFICATIONS: PRESENT IN ASSOCIATION WITH CARCINOMA AND BENIGN. BREAST TISSUE. SURGICAL MARGIN STATUS: NEGATIVE. INVASIVE CARCINOMA PRESENT 0.9 CM FROM. THE ANTERIOR MARGIN. ESTROGEN/PROGESTERONE RECEPTOR, CELL CYCLE, EGFR AND HER2/NEU ANALYSIS: NOT PERFORMED (SEE PREVIOUS BIOPSY REPORT. COMMENT: The ductal component from the needle core biopsy. is not. obvious in the resection specimen. The tumor contains areas of classic. lobular carcinoma as well as more solid areas that are comprised of small. nests of tumor cells which are interpreted as an acinar/solid component. I certify that I personally conducted the diagnostic evaluation of the above. rage J 01 J. specimen (s) and have rendered the above diagnosis (es) .

expanded version (tokens=1970) : 
 The breast pathology report indicates:

1. Histological Classification: Lobular invasive adenocarcinoma of the breast with type of in-situ carcinoma (ductal, solid type) and biopsy site changes, fibrocystic change.
2. Subtype: LumA
3. Necrosis: Absent.
4. Tumor Infiltrating Lymphocytes (TILs): Not mentioned.
5. Histological Grade: Nottingham combined histologic grade 2 of 3.
6. Nuclear Grade: The nuclear grade of in-situ carcinoma is 2 of 3.
7. Lymphovascular Invasion: Absent.
8. Calcification: Present in association with carcinoma and benign breast tissue.
9. Receptor Status: Estrogen/Progesterone receptor, cell cycle, EGFR and HER2/neu analysis were not performed (see previous biopsy report).
10. IHC and Ancillary Testing results: An immunohistochemical stain for cytokeratin is negative for tumor cells.

Additionally, the report indicates the size of the tumor and its invasive component, the absence of multifocal tumor, the status of surgical margins (negative) and lymph nodes (no evidence of metastatic carcinoma), and the presence of DCIS extending outside the invasive tumor mass at the edge of the tumor. The report also mentions the gross examination, block summary, surgical procedure and pathology stage based solely on the current tissue specimen being evaluated.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2150) : 
 The breast pathology report shows invasive lobular carcinoma of type LumA with fibrocystic change, absent necrosis and lymphovascular invasion. Necrotic tissue was not present. Tumor infiltrating lymphocytes were not mentioned. Histologic grade indicated a score of 2 of 3 and nuclear grade was 2 of 3 for the in-situ carcinoma component. The status of estrogen/progesterone receptor, cell cycle, EGFR, and HER2/neu was not provided. The margins were negative, and DCIS extended outside the tumor mass at the edge of the tumor. Three lymph nodes showed no evidence of metastatic carcinoma.

